Digital innovations are promoting HIV testing and prevention to MSM in Asia
Doravirine maintains higher rate of virological suppression over darunavir/ritonavir though 96 weeks of follow-up
Reduced dose darunavir/ritonavir effective and safe for people switching while virally suppressed
Three-quarters of deaths of people with HIV in London are due to non-AIDS conditions
Supervised drug consumption sites offer opportunities for HCV testing and treatment
HIV linked to higher risk of heart failure
Series of HIV outbreaks in people who inject drugs shows that ‘complacency is the new problem’
The kick that didn’t kill: first-ever randomised HIV cure study fails to eliminate infected cells
HIV elimination in gay men: what is working?
Kaposi's sarcoma remains a concern for people with HIV
Progress against HIV in young people lags behind as Africa's youth population grows
PrEP use linked to fewer new HIV infections in US states
HIV treatment services in African countries need to adapt to serve mobile and migrant populations
Test and treat studies show high rates of HIV diagnosis, viral suppression
Donor funding for HIV stalls, increasing pressure on high-burden countries to mobilise domestic resources
Universal test and treat greatly improves retention in care
Why are some countries slow to implement HIV treatment guidelines?
World experts publish consensus statement on the science of HIV in the context of criminal law
